Periodic Effects: Cannabis Business Podcast

(Part 2) with Dr. Robert Strongin, we dive into the chemistry & effects of vaping vs dabbing, inhalation toxicity & chemical changes of terpenes, vaping cannabis flower vs extracts and the synthetic production of the Delta-8 THC cannabinoid. Dr. Strongin is the Professor of Chemistry at Portland State University. P.S. World’s best search engine for Video Cannabis Education = PeriodicSearch.com Send a message with the “Contact Us” Button on PeriodicSearch.com homepage. Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) *read details for 1-on-1 calls in this calendar link

(Part 1) Dr. Robert Strongin has faced many uphill battles in his search for the truth. More recently he faced a media storm for his research on e-cigarettes and vaping, revealing some results the “Big Companies” weren’t too happy about. He’s also been researching the EVALI Outbreak that emerged in 2019. Dr. Strongin is the Professor of Chemistry at Portland State University. P.S. World’s best search engine for Video Cannabis Education = PeriodicSearch.com Send a message with the “Contact Us” Button on PeriodicSearch.com homepage. Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) *read details for 1-on-1 calls in this calendar link  

The United States Cannabis Council (USCC) was recently announced, and it raised many questions from people in the industry. Who’s behind this lobbying group and what are their interests? This could be great news for the industry and consumers across the country, or it could corrupt the waters and severely limit the future potential of cannabis. With a new group that could strongly influence federal cannabis policy reform, there are many questions to ask. Follow our guest, Brett Puffenbarger on Linkedin, for policy and industry updates. P.S. World’s best search engine for Video Cannabis Education = PeriodicSearch.com Send a message with the “Contact Us” Button on PeriodicSearch.com homepage. Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) *read details for 1-on-1 calls in this calendar link

From a 1-on-1 call. Corey and his team have been building value in a new and emerging dispensary business model. With their 1st two stores opening in Missouri, they’re ready to expand, but finding the right partners has been difficult. We review their marketing and sales strategy along with predictions on the future impacts of federal legalization. Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Sherice & Noel were carving out a new path in cannabis, with a service to contract out vendor days for brands. Then Covid hit, making a business model around in-person events a great uncertainty. They adapted by creating an online education platform to connect budtenders with brands, and it looks like the vendor day business is ramping up again. Listen to our guests reveal tips and tricks for in-store branding and their path in building a new market segment. Sherice Edmonds & Noel Adams are the Founders of Urban Yeti Events and Get Higher Education. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

(Part 2) Dr. Jeff Raber has a deep understanding of the lab and testing landscape in cannabis. As new processing techniques are being used to create cannabinoids outside of the plant, what does this mean for health, safety and analytical testing? We discuss what’s working well and what’s lacking for testing cannabis products for safety and compliance. Dr. Jeff Raber is CEO of The Werc Shop Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

(Part 1) Dr. Jeff Raber has seen the cannabis industry evolve. Initially getting his PhD in Organic Chemistry, in 2010 he started a cannabis lab for testing in Southern California. Since then he’s evolved his focus to include manufacturing and terpene production. We discuss his path through the industry, working in multiple States, and the science of cannabis and what’s still missing. Dr. Jeff Raber is CEO of The Werc Shop Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

(Part 2) Joseph Ramahi, PhD, a tissue culture specialist, discovered the difficulty of identifying Hop Latent Viroid (HpLVd) in cannabis and hemp plants, as it displayed both symptomatic and asymptomatic characteristics. HpLVd can lead to “dudding”, a stunted growth with less flower production and reduced trichomes. We discuss this discovery and the actions growers can take with our guest Joseph Ramahi, PhD, CSO of Cultivaris Hemp and on the board of Apical Biotek. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

(Part 1) Joseph Ramahi, PhD, a plant molecular biologist, was stunned as he discovered the widespread infection rates of Hop Latent Viroid (HpLVd) in cannabis crops. While this new viroid to cannabis was only publicly announced in 2019, it was initially discovered in the hops industry. We discuss the what, why, where and when of HpLVd with our guest Joseph Ramahi, PhD, CSO of Cultivaris Hemp and on the board of Apical Biotek. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

“Indica” & “Sativa” are often used to describe cannabis experiences, but the accuracy of these terms for predicting effects is hotly debated. Do “indica” and “sativa” strains actually have common terpenes that can consistently influence how you’ll feel on consumption? In this new podcast series, we’ll explore a study into the real chemistry behind the effects of sativa & indica cannabis by past guest Arno Hazekamp, PhD. Budtenders can join the [Pbs] FB Group Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message Paper Discussed [1] “Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification” by Arno Hazekamp, Katerina Tejkalová, and Stelios Papadimitriou

Arno Hazekamp, PhD (Part 2) discusses data correlations he discovered that might actually show Sativa & Indica do have specific types of terpenes, and therefore specific effects. Arno explains how terpenes and terpenoids are not the same thing, and how alcoholic terpenes (terpenoids) might be associated with Indica strains by influencing, or being a byproduct of, the growth properties of the cannabis plant. Arno’s Paper, Cannabis: From Cultivar to Chemovar II - A Metabolomics Approach to Cannabis Classification Learn about the work of Arno’s consultancy at Legal Cannabis Coalition Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Arno Hazekamp, PhD (Part 1) has been researching medicinal cannabis in Holland since 2001. We discuss transitioning from a cultivar to chemovar classification system for cannabis, and how this is needed to bridge the gap between patients, doctors, growers and products. In the second half of our conversation, Arno points out that indica and sativa might actually have specific terpenes associated with them, and therefore specific effects. Arno’s Paper, Cannabis: From Cultivar to Chemovar II - A Metabolomics Approach to Cannabis Classification Learn about the work of Arno’s consultancy at Legal Cannabis Coalition Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

A series not just for Budtenders. Let’s move beyond cannabinoids & terpenes to the more mysterious compounds of the cannabis leaves. Discover what science currently knows about Cannflavin A, Cannflavin B, and Bi-Benzyl compounds as well as the future potential of these trace cannabis molecules. Budtenders can join the [Pbs] FB Group Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

Sasha Kalcheff-Korn became the Education Coordinator at Realm of Caring (RoC) after teaching mathematics and getting her Masters in International Human Rights. RoC has the largest observational research registry on cannabis in partnership with Johns Hopkins University. We discuss that database, some studies and Sasha’s approach to educating different parts of the mainstream, like medical professionals, patients and the broader community. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Part 2 - Sam Chapman pictures a future medical mushroom program in Oregon with life-changing experiences available right next door for adults who can benefit from psilocybin. This would include a boom in job creation for facilitators & service centers to administer psilocybin therapy - but likely not as much opportunity on the supply side as in cannabis. Sam discusses the next two years of rulemaking for Measure 109’s program implementation, and how we can learn important lessons from cannabis’s legalization path. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Part 1 - Sam Chapman co-authored HB3460 in 2013, which legalized medical marijuana dispensaries in Oregon. More recently, Sam was the campaign manager of Measure 109 that passed and legalized a medical psilocybin program in Oregon. We discuss his advocacy journey from cannabis to psilocybin and what it looked like behind the scenes under such an unpredictable and dynamic landscape. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

From a 1-on-1 call with Wayne. Terese is a cannabis coach in Canada where many unknowns remain on the future landscape of cannabis markets. We discuss future predictions based on the current work Terese is doing and the changes taking place. If you’re a cannabis coach interacting with medical patients or consumers, this is a good episode to check out. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

Part 2 - Back with Dr. Sulak to discuss the use cases of new and emerging molecules in medicine, and how those might integrate around cannabis. We discuss the science of Kratom, Psilocybin and Ketamine. Covering the science currently known and unknown with these medicines and what the future landscape might look like. Our guest is Dr. Dustin Sulak, Founder of Healer Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

Part 1 - Dr. Sulak is a leading physician on integrating cannabis and other emerging plant medicines into his practice, while educating medical providers and patients on the clinical use of these medicines. We discuss “molecules” in this episode and their potential use cases. More so we discuss new findings and applications for cannabis molecules that have been sitting in the dark. Our guest is Dr. Dustin Sulak, Founder of Healer Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

From a 1-on-1 call with Wayne. Dr. Quinn owns a compounding pharmacy along with multiple ventures in the cannabis industry. We discuss a recent “hammer” big pharma dropped on the compounding world, which made a legal Cannabidiol product now illegal to use. And why the current insurance companies will never cover medical cannabis products from a compounding pharmacy. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)